Latest filing published 24 Dec 2014 for Cellular Biomedicine Group, Inc., €2.5M.
Insider track record
No signal scores available.
Pak To Leung: trading record in brief
Pak To Leung discloses dealings in Cellular Biomedicine Group, Inc. to SEC (Form 4). Activity is concentrated on a single trading day, 23 December 2014, with 2 filings.
The open-market record consists of 1 sale worth €1.6M, with no purchase. The rest of the record consists of 1 share grant.
The latest filing, published on 24 December 2014, reports a share grant of €2.5M in Cellular Biomedicine Group, Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Pak To Leung
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 380,000 shares@ US$8.00Common StockSEC:0001140361-14-046451:0
- 142,857 shares@ US$14.00Common StockSEC:0001140361-14-046451:1
2 of 2 declarations